Christopher Downs - 19 Nov 2021 Form 4 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role
Chief Financial Officer
Signature
/s/ Christopher Downs
Issuer symbol
CNSP
Transactions as of
19 Nov 2021
Net transactions value
+$5,192
Form type
4
Filing time
22 Nov 2021, 07:47:56 UTC
Next filing
07 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNSP Common Stock Purchase $5,192 +4,500 +3.2% $1.15 146,500 19 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $1.14 to $1.155. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.